Notably, our study demonstrated a marked increase in pro-tumor immune cells, such as M0 macrophages, in the high-risk group, whereas anti-tumor immune cells, including activated CD8+ T cells, were significantly more prevalent in the low-risk group. This evidence concerns the gene CD8A and neoplasm.